Dianthus Therapeutics, Inc. /DE/ insider trading

DNTHNASDAQ

$88.21-0.11 (-0.12%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+138.9%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23

Unlock quarterly net flow

Key players

MGMarino GarciaCEO AND PRESIDENT0.1167%of company
AMAdam M. VenessSVP, General Counsel and Sec.0.0268%of company
SRSimrat RandhawaEVP, Head of R&D0.0072%of company
RSRyan SavitzEVP, CFO & CBO0.00%of company
AMAnne McGeorgeDirector0.00%of company
ECEdward CarrCHIEF ACCOUNTING OFFICER0.00%of company
PSPaula SoteropoulosDirector0.00%of company
SRSimon ReadDirector0.00%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
No qualifying insider activity was found for the selected filters.

End of history · 0 transactions